PRP and PRF are both treatments made from your own blood, and they are often offered in the same clinics. People ask which is better. The sources we read do not agree, so this page shows what each says and where they differ. It does not pick one.
What each is
The American Academy of Dermatology (AAD), a society of dermatologists, describes platelet-rich plasma (PRP) as a procedure in which a small amount of your blood is drawn and placed in a machine that separates the platelets from the rest of the blood. The part with a high concentration of platelets is then injected into you. AAD says that in dermatology PRP is being tested as a treatment for hair loss, may speed wound healing, and is used by a few dermatologists for younger-looking skin.
Platelet-rich fibrin (PRF) is a related product. A 2022 review by Buzalaf and Levy in the Journal of Applied Oral Science describes PRP as the first-generation autologous platelet concentrate, and PRF and injectable PRF (i-PRF) as second- and third-generation products. The review says PRF and i-PRF are easier to obtain, and that at least in laboratory studies they seem to induce more collagen production than PRP, but that only a few clinical trials of them exist. This page reads only the abstracts of the journal articles it cites, not their full text.
What the evidence reviews say
A 2025 systematic review by Qin and colleagues in the Annals of Plastic Surgery looked at PRP and PRF for facial rejuvenation. It found 20 studies with 514 patients. The authors say effectiveness remains controversial, with studies yielding mixed results. They report significant improvement in 80% of the studies on skin thickness and 75% of those on elasticity, against 40% on wrinkles, 33% on texture and 17% on discoloration, and none on hydration. They say no serious adverse events were reported in the included studies, and they conclude that skin thickness and elasticity have the strongest evidence of improvement. This review combined PRP and PRF.
A 2025 systematic review by Sollitto and colleagues in the Journal of Cosmetic Dermatology compared PRP and PRF specifically around the eyes. It found 14 studies. The authors report that PRF was associated with improvements in skin texture, wrinkles and crepiness, and that PRP showed stronger evidence for treating hyperpigmentation. They conclude that current evidence does not support the superiority of one modality over the other, and that PRF improvements often diminished by 6 months.
A 2025 narrative review by Davies and Miron in Periodontology 2000 says few studies have compared PRP and PRF, and that all of those demonstrated superior outcomes with PRF. It says the existing studies have limitations including small sample sizes. One of its authors declares being the founder of BioPRF, a company in this field.
The AAD page on PRP says there is little evidence to show that it works or does not work, and that few studies exist because the FDA classifies PRP as a medical device, which has less demanding rules than a drug. Buzalaf and Levy conclude that results are in general favorable but that the quality of the studies is low.
What the reviews say
| Source | PRP | PRF |
|---|---|---|
| AAD (dermatologists' society) | PRP: Little evidence it works or does not | PRF: Not discussed |
| Buzalaf and Levy 2022 | PRP: First-generation product; most studied | PRF: Later generation; easier to obtain; few clinical trials |
| Qin et al. 2025 | PRP: Reviewed together with PRF | PRF: Reviewed together with PRP |
| Sollitto et al. 2025, eye area | PRP: Stronger evidence for pigmentation | PRF: Improvements in texture and fine lines; often faded by 6 months |
| Davies and Miron 2025 | PRP: Most studies are of PRP | PRF: Few comparisons, all favoring PRF; author linked to a PRF company |
What this means
The reviews disagree on whether PRF is better than PRP, and they agree that more and better trials are needed. One review of eye-area studies says the evidence does not support the superiority of either. Another says the few head-to-head studies favor PRF, and its author is connected to a PRF company. We cannot resolve this for you, and nothing here is advice on which to have.
Regulation
AAD says the FDA classifies PRP as a medical device. The FDA says microneedling devices are not approved for delivering blood products, such as PRP, into the skin. AAD describes microneedling with PRP as a treatment some dermatologists use. These are separate statements from separate sources. See our page on microneedling. If a clinic offers PRP or PRF, you can ask what it is used for, what device prepares it, and what evidence it relies on.
Questions to bring
About the treatment
About safety and cost
Where to go next
Sources
- AAD, Is platelet-rich plasma the secret to younger-looking skin? · American Academy of Dermatology (AAD), a non-profit professional organization of dermatologists · read 22 Oct 2026
- Buzalaf and Levy, Autologous platelet concentrates for facial rejuvenation, J Appl Oral Sci 2022 (abstract, PubMed 36074433) · Peer-reviewed review. Abstract read via the NCBI E-utilities service on 22 Oct 2026; full text not read. · read 22 Oct 2026
- Qin et al., Systematic Review of PRP and PRF in Facial Rejuvenation, Ann Plast Surg 2025 (abstract, PubMed 40167104) · Peer-reviewed systematic review. Abstract read via the NCBI E-utilities service on 22 Oct 2026; full text not read. · read 22 Oct 2026
- Sollitto et al., Systematic Review of PRP Versus PRF for Periorbital Rejuvenation, J Cosmet Dermatol 2025 (abstract, PubMed 41190633) · Peer-reviewed systematic review. Abstract read via the NCBI E-utilities service on 22 Oct 2026; full text not read. · read 22 Oct 2026
- Davies and Miron, Autologous platelet concentrates in esthetic medicine, Periodontol 2000 2025 (abstract, PubMed 39086171) · Peer-reviewed narrative review. One author declares being the founder of BioPRF. Abstract read via the NCBI E-utilities service on 22 Oct 2026; full text not read. · read 22 Oct 2026
- FDA, Microneedling Devices · US Food and Drug Administration (content current as of 10/15/2025 per the page) · read 22 Oct 2026